In our study, PD-L1 expression was not correlated with DFS or OS in patients with stage II and III NSCLC receiving adjuvant chemotherapy, consistent with the results in some previous studies [9–11]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.